Cited by 258Alzheimer's disease research and treatmentsCellular transport and secretionLysosomal Storage Disorders Research

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index; 25 of the 53 sources its claims cite were checked for support.

The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel β-Secretase (BACE1) Substrate

Open access

Abstract

BACE is a transmembrane protease with beta-secretase activity that cleaves the amyloid precursor protein (APP). After BACE cleavage, APP becomes a substrate for gamma-secretase, leading to release of amyloid-beta peptide (Abeta), which accumulates in senile plaques in Alzheimer disease. APP and BACE are co-internalized from the cell surface to early endosomes. APP is also known to interact at the cell surface and be internalized by the low density lipoprotein receptor-related protein (LRP), a multifunctional endocytic and signaling receptor. Using a new fluorescence resonance energy transfer (FRET)-based assay of protein proximity, fluorescence lifetime imaging (FLIM), and co-immunoprecipitation we demonstrate that the light chain of LRP interacts with BACE on the cell surface in association with lipid rafts. Surprisingly, the BACE-LRP interaction leads to an increase in LRP C-terminal fragment, release of secreted LRP in the media and subsequent release of the LRP intracellular domain from the membrane. Taken together, these data suggest that there is a close interaction between BACE and LRP on the cell surface, and that LRP is a novel BACE substrate.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

BACE1 interacts with the intracellular domain of LRP at the cell surface in lipid rafts, and this interaction leads to BACE-mediated cleavage of LRP. The authors conclude that LRP is a novel BACE1 substrate, processed in a manner analogous to APP.

Key findings

  • LRP and BACE co-immunoprecipitate: endogenous LRP light chain (~85 kDa) was pulled down with anti-BACE from human brain, and BACE bands (~60 and 75 kDa) were detected in mLRP1 immunoprecipitates from transfected H4 cells.
  • FLIM/FRET showed close proximity: BACE-V5 FITC lifetime was 2334 ± 72 ps alone vs. 2153 ± 55 ps with mLRP1-Myc-Cy3 (p < 0.0001); mLRP1-GFP was 2164 ± 10 ps alone vs. 1165 ± 8 ps with BACE-V5-Cy3 (p < 0.0001); endogenous N2a BACE-CT Alexa 488 was 1868 ± 116 ps alone vs. 1492 ± 293 ps with 11H4-Cy3 (p < 0.0001).
  • The interaction was weakened by cholesterol depletion (Myc-LC FITC + BACE-NT Cy3: 2023 ± 173 ps vs. 2203 ± 83 ps after depletion, p < 0.001), and an LC-LDLR chimera lacking the LRP intracellular domain did not FRET with BACE.
  • BACE activity increased LRP ectodomain shedding and LRP C-terminal fragment/intracellular domain release: WT-BACE increased SEAP-LRP shedding, catalytically inactive BACE D93/289A had no effect, BACE inhibitor and BACE siRNA reduced cleavage, and BACE co-transfection increased a 25-kDa LRP-CTF and LRP-Gal4/VP16 luciferase activity.

Methods

  • Cell systems included H4, mouse neuroblastoma N2a, pac1, LRP-deficient CHO 13-5-1, HEK293, and primary cortical neurons from embryonic day 16 CD1 mice; constructs included Myc-LC, mLRP1-Myc, mLRP1-GFP, LRP165-Myc, LC-LDLR, SEAP-LRP, LRP-Gal4-VP16, BACE-V5/Myc/GFP, and BACE mutants.
  • Protein interaction and localization were assessed by co-immunoprecipitation, immunocytochemistry/confocal microscopy, caveolae/noncaveolae fractionation, cholesterol depletion, human temporal cortex staining, and FLIM-based FRET.
  • Functional processing was assayed by BACE internalization assays in LRP-null cells, SEAP-LRP ectodomain secretion, Western blotting for LRP-CTF with DAPT, and luciferase reporter assay for LRP-ICD release; statistics used Student’s t test.

Limitations

  • Stated: whether LRP processing produces a stable LRP equivalent of Aβ is unknown; whether LRP-ICD has a transcriptional role under physiological conditions remains unknown; further studies are needed to determine if APP and LRP act co-operatively or competitively for secretase access and how LRP ligands affect these processes.
  • Stated: Fe65 and mDab1 did not appear to mediate the BACE-LRP interaction under the conditions used, though multiple other adaptor proteins might mediate or impact it.
  • Evident from the text: many interaction, shedding, CTF, and ICD experiments rely on transfected constructs and overexpression in cell lines; endogenous validation is limited to co-immunoprecipitation and FLIM in N2a cells, primary neurons, and human brain, with no in vivo causal test of LRP cleavage or downstream signaling.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1074/jbc.m414248200

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

25 of 53 cited sources checked · 12 supported · 0 flagged · accuracy not yet measured

Show all 54 claims

  • Probably not a substantial claim. 26
  • It may state two separate claims as one. 29
46 of 46
  • The paper relies on this without support.

    The mLRP1 and Myc-LC constructs are functionally similar to full-length LRP.

    “These constructs were used instead of full-length LRP because of its functional similarity to and better expression than full-length LRP.”
  • The paper relies on this without support.

    BACE directly cleaves LRP.

    “LRP is a novel BACE substrate.”
    “BACE induces LRP extracellular domain cleavage”
  • The paper relies on this without support.

    Cholesterol depletion with lovastatin/mevalonate and MβCD disrupts lipid rafts.

    “To test the hypothesis that this interaction occurs in rafts we cholesterol depleted the cells and repeated the cell surface FLIM experiment.”
    “Cholesterol depletion was performed with lovastatin/mevalonate for 24 h and M␤CD for 10 min.”
  • The authors state this as an assumption.

    FRET requires the two fluorophores to be within less than 10 nm of each other.

    “The two fluoro-phores must be quite close (Ͻ10 nm) to support FRET; tagging LRP and BACE molecules “across the membrane” from one another or after cholesterol depletion abolishes FRET despite continued co-localization at the light level.”
  • The paper relies on this without support.

    LRP is highly enriched in lipid rafts.

    “Thus, LRP, which is highly enriched in rafts, potentially acts as a scaffolding complex in rafts for APP and for BACE; such an interaction may help explain the observations that directing APP to rafts enhances ␤-cleavage and A␤ generation (13).”
  • The paper relies on this without support.

    BACE D93/289A is catalytically inactive.

    “WT-BACE led to a significant increase in LRP ectodomain shedding compared with baseline, whereas, as expected, catalytically inactive BACE D93/289A exhibited no effect (Fig. 7A).”
  • The paper relies on this without support.

    BACE1-specific siRNA specifically knocks down BACE.

    “Knocking down overexpressed BACE by co-transfection of BACE1-specific siRNA reduced processing of LRP by BACE (Fig. 7C).”
  • The paper relies on this without support.

    The 25-kDa band detected by Western blot is LRP-CTF.

    “This led to an increase of LRP-CTF detected by Western blot as a 25-kDa band.”
8 of 8

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • Whole-cell lysate assigned to conflicting lanes

    Minor

    The results text places the whole-cell lysate for Figure 3A in lane 4, but the Figure 3A caption identifies lane 5 as the positive-control lysate.

1 of 1

Citations

Cites

Flagged first, then by citations

Show all 50 references

Cited by

Sorted by citations

Metadata

Authors
von Arnim, C. A. F., Kinoshita, A., Peltan, I. D., Tangredi, M. M., Herl, L., Lee, B. M., Spoelgen, R., Hshieh, T. T., Ranganathan, S., Battey, F. D., Liu, C.-X., Bacskai, B. J., Sever, S., Irizarry, M. C., Strickland, D. K., & Hyman, B. T.
Affiliations
Harvard University (US)
Corresponding author
Hyman, Bradley T.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2005-05
Volume
280
Issue
18
Pages
17777-17785
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2137023074
Cited by
258
References
50
Citations by year
2026: 5 · 2025: 3 · 2024: 5 · 2023: 2 · 2022: 6 · 2021: 7 · 2020: 3 · 2019: 7 · 2018: 6 · 2017: 12 · 2016: 11 · 2015: 11 · 2014: 12 · 2013: 19 · 2012: 24
FWCI
7.15
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • American Federation for Aging Research
  • Deutsche Forschungsgemeinschaft
  • National Institutes of Health (AG15379)
  • National Institute on Aging (P01AG015379, AG 12406, P50AG005134)
  • National Heart, Lung, and Blood Institute (R01HL050784, P01HL054710)
  • National Institute of Biomedical Imaging and Bioengineering (R01EB000768)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
  • Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
Keywords
low density lipoprotein receptor-related protein, BACE1, beta-secretase, amyloid precursor protein, lipid rafts, Alzheimer's disease, amyloid-beta, endocytosis
MeSH terms
Animals, Cricetinae, Humans, Endopeptidases, Substrate Specificity, Aspartic Acid Endopeptidases, CHO Cells, Low Density Lipoprotein Receptor-Related Protein-1, Cell Line, Tumor, Mice, Amyloid Precursor Protein Secretases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review